A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors (Q33732128)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors |
scientific article |
Statements
1 reference
A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors (English)
1 reference
Jhanelle E Gray
1 reference
Eric Haura
1 reference
Alberto Chiappori
1 reference
Tawee Tanvetyanon
1 reference
Charles C Williams
1 reference
Mary Pinder-Schenck
1 reference
Julie A Kish
1 reference
Jenny Kreahling
1 reference
Richard Lush
1 reference
Anthony Neuger
1 reference
Leticia Tetteh
1 reference
Angela Akar
1 reference
Xiuhua Zhao
1 reference
Michael J Schell
1 reference
Gerold Bepler
1 reference
Soner Altiok
1 reference
15 January 2014
1 reference
1 reference
20
1 reference
1644-1655
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference